Gorlin syndrome is a genetic condition that affects the skin, bones, and other tissues. People with Gorlin syndrome often develop many basal cell skin cancers, jaw cysts, small pits on the palms or soles, and distinctive facial features. Signs usually begin in childhood or the teen years and continue lifelong, but severity varies. Most people with Gorlin syndrome live a normal lifespan, though they need regular checks for skin cancers and other features. Treatment focuses on removing skin cancers, monitoring jaw cysts and the brain and heart when needed, and using sun protection and targeted medicines.
Overview
Gorlin syndromeSymptoms
Gorlin syndrome features include early multiple basal cell skin cancers, jaw cysts causing swelling or crowded teeth, and pits on the palms or soles. Others may have a high forehead and rib or spine differences, with signs noticed in childhood.
Outlook and prognosis
Most people with Gorlin syndrome live a normal lifespan. The biggest long-term issues are repeated skin cancers, jaw cysts, and occasional tumors, which often need ongoing checks and timely treatment. Regular dermatology, dental, and imaging follow-up helps prevent complications.
Causes and risk factors
Gorlin syndrome stems from inherited or new PTCH1 changes, less often PTCH2 or SUFU, disrupting a growth-control pathway. Autosomal dominant inheritance gives a 50% chance to each child. Sun/UV and radiation exposure increase cancer risk; lighter skin may heighten sensitivity.
Genetic influences
Genetics are central in Gorlin syndrome. Most people inherit a PTCH1 gene change; others have new (de novo) variants or less commonly SUFU variants. Genetic testing confirms the diagnosis, guides cancer surveillance, informs family planning, and identifies at‑risk relatives.
Diagnosis
Doctors diagnose Gorlin syndrome using clinical features, imaging, and family history. Typical findings include early skin cancers, jaw cysts, or specific bone changes, and genetic testing can confirm the diagnosis, including the genetic diagnosis of Gorlin syndrome.
Treatment and drugs
Gorlin syndrome care focuses on regular skin checks, gentle sun protection, and early treatment of basal cell cancers with creams, freezing, laser, or surgery. Some benefit from targeted medicines that block the hedgehog pathway. Dental, jaw, and brain imaging are tailored to age and findings.
Symptoms
Some people notice skin changes at a young age, jaw swelling, or tiny pits on the palms that catch water. These can be early features of Gorlin syndrome, a genetic condition that mainly affects the skin, jaw, and bones. Features vary from person to person and can change over time.
Small, shiny bumps, scaly patches, or sores that don’t heal may appear in the teens or 20s. People with Gorlin syndrome often develop many basal cell skin cancers earlier than expected. These can show up on sun‑exposed or covered skin.
Tiny depressions on the palms or soles look like small dots that fill with water or sweat. They usually don’t hurt but are a common clue to Gorlin syndrome. You may notice them after a bath or swim.
Painless or aching swelling in the jaw can push teeth out of place or delay tooth eruption. Dentists often spot these cysts on routine X‑rays or a dental panoramic scan. These jaw cysts are frequent in Gorlin syndrome.
A broad forehead, wide‑set eyes, and a larger head size are common. Helmets or hats may feel snug even when clothing fits normally. These traits are present from childhood.
How people usually first notice Gorlin syndrome?
Many families first notice Gorlin syndrome when a child has small skin pits on the palms or soles, unusually wide-set eyes, or a larger head size, prompting a checkup. Doctors may suspect it earlier if a prenatal or childhood ultrasound shows tiny calcium spots in the brain called calcifications, or if jaw X‑rays in later childhood reveal cysts that can cause swelling or delayed tooth eruption. For teens and adults, the first signs of Gorlin syndrome are often multiple early basal cell skin cancers or frequent jaw cysts, leading to genetic evaluation.
Types of Gorlin syndrome
Gorlin syndrome can look different from one person to the next, and several clinical variants have been described based on gene changes and how early features appear. Most people have changes in the PTCH1 gene, while others have SUFU variants that carry different risks, especially for childhood brain tumors. A few families have been reported with other pathway gene changes, but PTCH1 and SUFU remain the well-recognized types of Gorlin syndrome. Not everyone will experience every type.
PTCH1-related type
This is the most common variant, often linked with multiple skin basal cell cancers over time and jaw cysts starting in adolescence or early adulthood. People may also have small pits on the palms and soles, bone changes, and a higher sensitivity to sunlight.
SUFU-related type
This variant carries a higher risk of early-life medulloblastoma, especially in young children, while skin basal cell cancers may be fewer or appear later. Care teams often recommend earlier and more frequent brain monitoring in childhood.
Mosaic Gorlin syndrome
Changes are present in some cells but not all, which can make features patchy or limited to certain body areas. Symptoms may be milder or appear on one side, but cancer risks can still be present and need tailored screening.
Rare pathway variants
Very rare changes in other Hedgehog-pathway genes have been reported in a few families and may resemble PTCH1-related disease. These are uncommon, and genetic testing usually focuses first on PTCH1 and SUFU when evaluating types of Gorlin syndrome.
What genetics can tell you about symptoms
Some people with PTCH1 changes develop many early basal cell skin cancers, jaw cysts, and small pits on the palms or soles because this gene normally helps keep cell growth signals in check. SUFU variants are linked to a higher risk of childhood medulloblastoma and fewer skin cancers.
Causes and risk factors
Most cases happen because of a change in a growth control gene called PTCH1, and less often in a related gene called SUFU.
The gene change can be inherited from a parent, giving each child a 50% chance, or it can occur for the first time in a child.
Doctors distinguish between risk factors you can change and those you can’t.
Sun exposure and tanning beds are modifiable risk factors for Gorlin syndrome, so consistent sun protection and avoiding tanning help.
Radiation therapy and frequent high-dose X-rays can raise tumor risk, while fair skin and childhood blistering sunburns can add to the burden in people with Gorlin syndrome.
Environmental and biological risk factors
For Gorlin syndrome, the chance of it occurring mostly reflects internal biology set very early in life. Doctors often group risks into internal (biological) and external (environmental). At this time, environmental risk factors for Gorlin syndrome are not well defined, and few outside exposures have been shown to change the chance of it happening.
Gorlin syndrome arises from biological changes that happen very early in fetal development. These are internal body factors rather than outside exposures.
Older parent age is linked to more new changes at conception across many conditions. A clear, syndrome-specific link for Gorlin syndrome has not been firmly shown.
High-dose ionizing radiation during pregnancy can disrupt development, but it has not been shown to cause Gorlin syndrome. Medical teams keep diagnostic radiation as low as reasonably possible.
No particular chemical, medication, or pollutant has been proven to raise the chance of Gorlin syndrome. Avoiding harmful substances is important for general pregnancy health, but a direct link to this syndrome is unproven.
Genetic risk factors
Most cases of Gorlin syndrome trace back to a single gene change that alters how cells grow. The genetic causes of Gorlin syndrome center on the Hedgehog signaling pathway, especially the PTCH1 and SUFU genes. It follows an autosomal dominant pattern, so a single altered copy can be enough and there’s a 50% chance to pass it on with each pregnancy. People with the same risk factor can have very different experiences.
PTCH1 variants: Most cases are due to a harmful change in the PTCH1 gene, which helps keep cell growth in check. A single altered copy can raise the lifetime chance of basal cell skin cancers and jaw cysts. This often explains a pattern that shows up across generations.
SUFU variants: A smaller group of people have changes in the SUFU gene. These variants bring a higher risk of childhood medulloblastoma and tend to cause fewer jaw cysts than PTCH1 changes.
Autosomal dominant inheritance: Gorlin syndrome is inherited in an autosomal dominant way. If a parent carries a PTCH1 or SUFU change, each child has a 50% chance to inherit it.
De novo changes: Sometimes the gene change appears for the first time in a child without a prior family history. In these cases, parents usually test negative, and the chance of it happening again in another child is low but not zero due to possible germline mosaicism.
Mosaicism: In some people, only a portion of cells carry the gene change, called mosaicism. This can lead to milder or patchy features and can make genetic testing less straightforward.
Family history: Having a parent or sibling with a confirmed PTCH1 or SUFU variant is a strong genetic risk factor. Subtle signs in relatives can sometimes reflect the same underlying change.
Hedgehog pathway: PTCH1 and SUFU are gatekeepers for the Hedgehog signaling pathway that guides cell growth. When one copy is altered, the pathway can become overactive, which sets the stage for tumor formation in certain tissues.
Variable expressivity: Not everyone with the same gene change develops the same pattern of findings. Some may have early symptoms of Gorlin syndrome in childhood, while others notice features later in adolescence or adulthood.
PTCH1 deletions: Rarely, a larger missing piece of chromosome 9 that includes PTCH1 causes Gorlin syndrome. This deletion can bring the usual risks plus additional developmental features depending on which neighboring genes are lost.
Lifestyle risk factors
Gorlin syndrome is a genetic condition; lifestyle habits do not cause it but can influence how many skin cancers develop, how well surgeries heal, and how musculoskeletal or dental issues are managed. Understanding how lifestyle affects Gorlin syndrome helps you reduce avoidable complications and treatment burden. Below are lifestyle risk factors for Gorlin syndrome that you can modify to support safer, smoother care.
Ultraviolet light accelerates the development of basal cell carcinomas in Gorlin syndrome. Limiting midday sun time can reduce how many new lesions appear.
Tanning beds deliver intense UV that can sharply increase basal cell carcinoma counts in Gorlin syndrome. Avoiding tanning devices lowers surgical procedures and scarring.
Inconsistent use of sunscreen, hats, and UV-protective clothing allows cumulative UV that speeds skin tumor formation. Daily, year-round protection can reduce tumor burden.
Long hours outside without shade or protective gear add high UV doses and increase the need for skin surgeries in Gorlin syndrome. Planning shade breaks and protective clothing mitigates risk.
Risk prevention
Gorlin syndrome is a lifelong, inherited condition, so the focus is on lowering complications, catching problems early, and protecting skin and bones over time. Prevention is about lowering risk, not eliminating it completely. Practical steps—like strong sun protection and regular check-ins with your care team—can make a meaningful difference. Early, tailored monitoring helps find skin cancers and jaw cysts when they are easiest to treat.
Daily high‑SPF sunscreen, sun‑protective clothing, hats, and shade limit UV damage that fuels skin cancers in Gorlin syndrome. Avoid peak sun and never use tanning beds.
Schedule routine dermatology exams to spot and treat basal cell cancers early. Catching small spots sooner usually means simpler treatment and fewer scars.
Ask whether ultrasound or MRI can replace X‑rays or CT when appropriate, and use shielding if imaging is necessary. People with Gorlin syndrome are more sensitive to radiation, which can raise skin‑cancer risk.
Regular dental visits help find jaw cysts before they cause pain or swelling. Dentists can plan imaging with the lowest possible radiation or MRI when feasible.
Transmission
Gorlin syndrome is not contagious—you can’t catch it from touch, coughing, or blood. It is passed through families in an autosomal dominant pattern, meaning that if a parent has Gorlin syndrome, each child has a 50% chance of inheriting the gene change. In some people there’s no family history because the change happens for the first time (a new mutation). If you have questions about how Gorlin syndrome is inherited and the genetic transmission of Gorlin syndrome, genetic counseling can help clarify risks and testing options.
When to test your genes
Gorlin syndrome is genetic, so test genes when there’s a suggestive pattern: multiple early basal cell skin cancers, jaw cysts, pits on palms/soles, or a family history. Children with features should be tested promptly to guide imaging, sun protection, and targeted care. Relatives of someone diagnosed should consider testing to clarify their own risks and screening.
Diagnosis
Diagnosis of Gorlin syndrome usually starts with patterns doctors notice during routine care, such as early skin changes or jaw cysts found by a dentist. Getting a diagnosis is often a turning point toward answers and support. Doctors combine what they see on exam and imaging with targeted genetic tests; this approach is often called the genetic diagnosis of Gorlin syndrome. Family history can also point the way because the condition often runs in families.
Doctors look for a combination of early or multiple skin cancers, tiny pits on the palms or soles, and jaw cysts. These features, when seen together, strongly suggest Gorlin syndrome.
A detailed family and health history can help connect symptoms across generations. If close relatives have similar findings, that raises the likelihood and guides testing.
Dermatology checks for numerous or early-onset basal cell skin cancers and subtle skin findings like palmar or plantar pits. Photographs over time can help track changes.
Dentists often order a panoramic jaw X-ray to look for characteristic cysts in the jaw. Finding these cysts at a young age supports the diagnosis of Gorlin syndrome.
Stages of Gorlin syndrome
Gorlin syndrome does not have defined progression stages. It’s a lifelong genetic condition where features can appear at different ages and vary from person to person, so it doesn’t follow a steady, stepwise decline. Doctors consider patterns—such as early symptoms of Gorlin syndrome like frequent skin growths, jaw cysts, or distinctive bone findings—and your family history, and may confirm with genetic testing; Different tests may be suggested to help build a clear picture. Ongoing care often includes regular skin checks and dental imaging to watch for changes over time.
Outlook and prognosis
Looking at the long-term picture can be helpful. For most people with Gorlin syndrome, life expectancy is near normal, but the condition brings ongoing care needs. The biggest issues tend to be frequent skin cancers called basal cell carcinomas, along with jaw cysts and sun sensitivity. Early symptoms of Gorlin syndrome might show up in the teen years or early adulthood, such as new skin spots that don’t heal or a painless swelling in the jaw noticed during dental X‑rays.
The outlook is not the same for everyone, but many living with Gorlin syndrome do well when skin checks and dental monitoring are routine. Most basal cell cancers grow slowly and are treatable when found early, though repeated procedures can be burdensome and sometimes leave scars. Rarely, complications can be serious—like very aggressive skin cancers, brain tumors in childhood (medulloblastoma), or cysts that get infected—so staying on top of screening is key. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including how much UV exposure you get and how quickly treatments are started.
With ongoing care, many people maintain work, family life, and activities they enjoy. Mortality is low overall, but risk rises if cancers are ignored or if a fast-growing tumor appears early in life. Talk with your doctor about what your personal outlook might look like. Genetic testing can sometimes provide more insight into prognosis, and it may guide which screenings and treatments fit you best.
Long-term effects
Gorlin syndrome tends to bring health features that unfold from childhood into adulthood. Early symptoms of Gorlin syndrome can include jaw cysts or small pits on the hands and feet, while skin cancers often appear later. Long-term effects vary widely, with some people having only a few issues and others facing repeated treatments over the years.
Many develop multiple basal cell skin cancers over time, often starting in adolescence or young adulthood. These growths tend to come back in new spots, especially on sun‑exposed areas.
Recurrent cysts in the jaws can grow slowly and shift or loosen teeth. They may come back even after removal and can occur on either side.
Tiny depressions on the palms and soles can become more noticeable with age. They are a common, lasting feature in people with Gorlin syndrome.
Rib shape changes, spine curvature, and a larger head size can be part of the long‑term picture. These bone traits usually stay stable once growth is complete.
How is it to live with Gorlin syndrome?
Daily life with Gorlin syndrome often means planning around regular skin checks, occasional procedures to remove basal cell carcinomas, and monitoring for jaw cysts or other features, all while trying to keep routines like work, school, and family time steady. Sun protection becomes a daily habit—wide-brim hats, UV-protective clothing, shade, and diligent sunscreen—which can feel limiting but meaningfully reduces new skin cancers. For many, the condition is manageable with a trusted care team, though the cycle of surveillance and treatment can be tiring and may bring worries about scarring, costs, or genetic implications for children. Loved ones often play a key role—helping with appointments, reinforcing sun-safe habits, and offering emotional support—which can strengthen relationships but also asks for shared patience and understanding.
Treatment and drugs
Gorlin syndrome treatment focuses on preventing skin cancers, treating tumors early, and protecting sensitive tissues like the skin and jaw. Dermatology care is central: regular skin checks, sun protection, and timely removal of basal cell skin cancers with methods like creams, freezing, light therapy, or surgery; for many, oral or topical hedgehog pathway inhibitors are used when cancers are numerous or hard to remove. Jaw cysts are monitored with dental X‑rays and usually treated by careful surgical removal to lower the chance of return, and neurosurgical care may be needed if brain tumors appear. Alongside medical treatment, lifestyle choices play a role, including strict sun protection, avoiding tanning beds and unnecessary radiation, and using protective clothing and high‑SPF sunscreen. You might picture this as a team effort between you and your doctor, with coordinated care from dermatology, dentistry/oral surgery, genetics, and other specialists to tailor treatment over time.
Non-drug treatment
Non-drug care for Gorlin syndrome focuses on prevention, early detection, and procedures that remove growths while preserving healthy tissue. Non-drug treatments often lay the foundation for long-term management and can reduce how often you need medicines or more invasive care. Regular checkups help catch early symptoms of Gorlin syndrome, such as new skin spots or changes in the jaw. Plans are tailored by age and personal risk, and they often shift over time.
Daily broad-spectrum sunscreen, protective clothing, and shade lower UV damage and help prevent new skin cancers. Avoid tanning beds and peak sun when possible.
Dermatology visits every few months and monthly self-checks help spot new or changing lesions early. This is especially important in Gorlin syndrome, where new spots can appear frequently.
Surgical removal of individual skin cancers can fully clear them in one visit. It’s useful for tumors that are not ideal for tissue-sparing methods.
Layer-by-layer removal maps and clears cancer while saving as much healthy skin as possible. It’s often chosen for facial areas or recurring tumors to protect appearance and function.
Your genes may have an impact on how drugs work for you
Medicines for Gorlin syndrome can work differently depending on your genes, which affect how your body activates, breaks down, or responds to a drug. Genetic testing can sometimes guide dosing or choice of treatments, aiming for better results with fewer side effects.
Pharmacological treatments
Medicines for Gorlin syndrome mainly aim to prevent or treat the many basal cell skin cancers so daily life involves fewer procedures and recoveries. Not everyone responds to the same medication in the same way. Drug therapy does not change early symptoms of Gorlin syndrome such as jaw cysts, but it can reduce the number or size of skin cancers and help space out surgeries. Your care team will match treatments to your goals, the type of lesions, and plans for pregnancy.
Taken by mouth to shrink or control multiple basal cell skin cancers. It blocks the Hedgehog pathway that drives many of these tumors in people with Gorlin syndrome. Pregnancy must be strictly avoided and common effects include muscle cramps and taste changes.
Another oral Hedgehog‑pathway blocker for widespread or hard‑to‑treat basal cell cancers. Some switch to this if the other option isn’t tolerated or stops working. Regular blood tests and pregnancy precautions are required.
A prescription skin cream for some superficial basal cell cancers. It boosts local immune activity to clear shallow spots and may reduce the need for surgery in selected areas. Redness and irritation at the application site are common.
A topical chemotherapy cream for superficial basal cell cancers. It targets fast‑growing cells in the top skin layers. The treated area often becomes red and scaly before healing.
Genetic influences
In many families, Gorlin syndrome shows up across generations. It’s usually passed down: if a parent has the condition, each child has a 50% (1 in 2) chance to inherit the gene change. Still, about a quarter of people develop Gorlin syndrome because of a new change in the gene, so there may be no prior family history. Most often the change is in a gene called PTCH1, and less often in SUFU; these genes normally help keep cell growth in check. Even with the same gene change, people can have very different features and timing of early symptoms of Gorlin syndrome. Genetic testing for Gorlin syndrome can confirm the cause, guide screening plans, and help families understand risks for children and siblings. Changes in SUFU are linked with a higher chance of certain childhood brain tumors, so knowing the exact gene can shape which scans and checkups are recommended.
Is Gorlin syndrome genetic?
Genetics are central in Gorlin syndrome. Most people inherit a PTCH1 gene change; others have new (de novo) variants or less commonly SUFU variants. Genetic testing confirms the diagnosis, guides cancer surveillance, informs family planning, and identifies at‑risk relatives.
Pharmacogenetics—how genetics influence drug effects
For many living with Gorlin syndrome, treatment choices are closely tied to the same gene changes that drive the condition. Because changes in genes such as PTCH1 or SUFU keep the “Hedgehog” growth pathway switched on, doctors may use targeted medicines called Hedgehog pathway inhibitors (like vismodegib or sonidegib) to lower the number and size of basal cell skin cancers. Pharmacogenetic testing for Gorlin syndrome isn’t routinely used to choose or dose these drugs, and people may experience different side effects such as muscle cramps, taste changes, or hair thinning. Not every difference in response is genetic, but other factors—age, overall health, other medicines, and how extensive the skin cancer burden is—can affect how well treatment works and how it feels day to day. Sonidegib is processed by a major liver enzyme, so strong antifungals or certain antibiotics can raise its level, while some seizure medicines or herbal products like St. John’s wort can lower it; your care team will review other prescriptions carefully. Because radiation can trigger new skin cancers in Gorlin syndrome, care plans usually avoid radiotherapy and lean on surgery, close skin checks, and, when appropriate, Hedgehog inhibitors guided by a confirmed genetic diagnosis.
Interactions with other conditions
Day to day, managing Gorlin syndrome often means keeping up with skin checks while also watching for tumors in other parts of the body. Some early symptoms of Gorlin syndrome can overlap with common skin issues, so basal cell cancers may be mistaken for stubborn “spots,” and jaw cysts may first be picked up by a dentist rather than linked to the syndrome. Children with Gorlin syndrome have a higher risk of a brain tumor called medulloblastoma, and some adults develop ovarian or cardiac fibromas; care teams usually coordinate imaging and follow-up so one plan covers these linked risks. Treatments for other illnesses can affect Gorlin syndrome too: radiation therapy used for unrelated cancers or skin conditions can trigger many new skin cancers, so doctors often choose non-radiation options when possible. Medicines that lower the immune system, such as after an organ transplant or for autoimmune disease, may also increase the number or speed of skin cancers, so dermatology follow-up becomes even more important. Ask if any medications for one condition might interfere with treatment for another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described families in which several relatives developed many skin bumps, needed repeated treatments, and had unusually wide-set eyes or jaw cysts in their teens. Community stories often described the condition as “those stubborn skin tumors that keep coming back,” long before doctors connected the dots and recognized a pattern now known as Gorlin syndrome.
First described in the medical literature as multiple recurring skin cancers in young people, early reports focused on what could be seen: frequent basal cell skin cancers, jaw cysts found on dental X-rays, and distinctive facial features. In the mid-20th century, detailed family studies showed that these features tended to appear together and often passed from parent to child. Over time, descriptions became more precise, separating Gorlin syndrome from look-alike conditions and noting that the number of skin cancers could vary widely, especially with sun exposure and skin tone.
As medical science evolved, doctors added less visible features to the picture, including small pits on the palms and soles, tiny calcifications in the skull seen on imaging, and an increased risk for certain childhood tumors. These findings helped clinicians diagnose Gorlin syndrome earlier, sometimes before the first skin cancer showed up. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Advances in genetics in the 1990s and 2000s identified changes in a gene that helps control a growth pathway acting like a dimmer switch for cell division. This discovery confirmed why people with Gorlin syndrome develop frequent skin cancers and cysts, and why careful screening across life stages matters. It also explained the inheritance pattern seen in families: a child has a 50% chance of inheriting the condition when one parent is affected, though the severity can differ even within the same family.
With each decade, management has shifted from reacting to problems toward prevention and early detection. Sun protection, regular skin checks, dental and jaw imaging in adolescence, and tailored imaging for higher-risk ages became part of routine care. In recent decades, awareness has grown that Gorlin syndrome affects people of all backgrounds, that skin findings can be subtle in darker skin tones, and that minimizing needless radiation exposure in imaging is important for children with this condition.
Today’s understanding of Gorlin syndrome blends careful clinical observation with genetic insights. Knowing the condition’s history helps explain why a thorough family review, a full skin and dental exam, and thoughtful use of imaging remain central—and why coordinated care can reduce procedures, catch early symptoms of Gorlin syndrome, and support long-term health.